Univ.-Prof. Dr. Dr. Philipp Schommers
Education and Professional Career
- since 2024: Else Kröner Clinician Scientist Professor for internal Medicine (W2)
- since 2024: Senior Physician (‘Oberarzt’) Department I of Internal Medicine, University Hospital Cologne, Germany
- since 2022: Emmy Noether Research Group Leader Department I of Internal Medicine, University Hospital Cologne, Germany
- 2022: Habilitation (Priv.-Doz.) Venia legendi Internal Medicine University of Cologne
- 2022: Board Certification in Infectious Diseases, German Society of Infectious Diseases (DGI)
- 2021: Board Certification in Internal Medicine, Medical Association of North Rhine (ÄkNo)
- 2020: PhD Thesis (Dr. nat. med.): “Restriction of HIV-1 Escape by a Novel Highly Broad and Potent Neutralizing Antibody” (“summa cum laude”, highest honor)
- since 2018: Physician and Clinician Scientist, Department I of Internal Medicine, University Hospital Cologne, Germany Advisor: Prof. Michael Hallek
- 2016 - 2022: Postdoctoral Associate, Institute of Virology, University of Cologne, Germany, Advisor: Prof. Florian Klein
- 2015 - 2016: Postdoctoral Associate, Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany, Advisor: Prof. Marcus Altfeld
- 2015: MD Thesis (Dr. med.): ”Überleben und Mortalität verschiedener HIV-assoziierter Lymphome - Ergebnisse der deutschen HIV-Lymphom-Kohorte“ (“summa cum laude”, highest honor)
- 2013 - 2015: Physician and Clinician Scientist, Department I of Internal Medicine, University Hospital Cologne, Germany Advisor: Prof. Michael Hallek
- 2013: Scientific Assistant, Institute for Vegetative Physiology, Center for Physiology and Pathophysiology, University of Cologne, Advisor: Prof. Rudolf Wiesner
- 2013: Final medical exam
- 2007 - 2013: Medical Studies - Germany, Australia and United States
Awards, distinctions and professional activities
- 2023: Else Kröner Clinician Scientist Professorship - EKFS
- 2023: 72nd Lindau Nobel Laureate Meeting – Visiting Scientist
- since 2022: Emmy Noether Grant – German Research Foundation (DFG)
- 2021-2023: Gilead Research Scholars Program in HIV – Gilead Sciences, Inc.
- 2022: Science Award - Industrie-Club E.V. Düsseldorf
- 2021: German Thesis Award – Körber Foundation
- 2021: German AIDS Award – German AIDS Society (DAIG)
- 2021: HIV/AIDS Research Award – German Society of Infectious Diseases (DGI)
- 2020: Wolfgang Stille Award – Paul-Ehrlich-Society of Chemotherapy (PEG)
- 2020: Graduate Stipend – Novartis foundation for therapeutic research
- 2017: Meta Alexander Award – German Society of Infectious Diseases (DGI)
- 2017 - 2018: MD/PhD Stipend – German Center for Infection Research (DZIF)
- 2016: Lab Rotation Stipend – German Center for Infection Research (DZIF)
- 2015 - 2016: Clinical Leave Stipend – German Center for Infection Research (DZIF)
- 2010 - 2012: Maria-Pesch Scholarship – State of North Rhine-Westphalia
Memberships
- German Society for Internal Medicine (DGIM)
- German Society of Infectious Diseases (DGI)
- Paul-Ehrlich-Society of Chemotherapy (PEG)
- Deutscher Hochschulverband
Patents
EP 23203489.2
Title: Improved Broadly Neutralizing Antibodies Targeting the CD4 Binding Site on HIV Env
Inventors: Florian Klein, Philipp Schommers, Henning Gruell
Status: Submitted to European Patent Office in 2023
EP 19212986.4
Title: Broadly Neutralizing Antibodies Against HIV
Inventors: Florian Klein, Philipp Schommers, Henning Gruell
Status: Licensed in 2022
